WESPAC Advisors LLC Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

WESPAC Advisors LLC acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, HoldingsChannel reports. The fund acquired 1,574 shares of the financial services provider’s stock, valued at approximately $229,000.

Several other institutional investors also recently bought and sold shares of IBB. O Shaughnessy Asset Management LLC boosted its stake in shares of iShares Biotechnology ETF by 19.5% in the first quarter. O Shaughnessy Asset Management LLC now owns 1,986 shares of the financial services provider’s stock valued at $273,000 after purchasing an additional 324 shares during the period. Flow Traders U.S. LLC boosted its stake in shares of iShares Biotechnology ETF by 873.2% in the first quarter. Flow Traders U.S. LLC now owns 22,802 shares of the financial services provider’s stock valued at $3,129,000 after purchasing an additional 20,459 shares during the period. Econ Financial Services Corp purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $398,000. Waverly Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 80.6% in the first quarter. Waverly Advisors LLC now owns 11,220 shares of the financial services provider’s stock valued at $1,540,000 after purchasing an additional 5,006 shares during the period. Finally, BTG Pactual Global Asset Management Ltd purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at $1,314,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $137.96 on Friday. iShares Biotechnology ETF has a twelve month low of $117.28 and a twelve month high of $150.57. The firm has a fifty day simple moving average of $143.43 and a 200-day simple moving average of $141.81.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.